Medical Treatment for Anal Warts

First-Line Treatment Approach

The American College of Physicians recommends cryotherapy with liquid nitrogen applied every 1-2 weeks as the primary treatment for external anal warts, with trichloroacetic acid (TCA) 80-90% as an equally effective alternative 1
Cryotherapy has an efficacy range of 63-88% with recurrence rates of 21-39% 1
TCA 80-90% achieves 81% efficacy with a 36% recurrence rate 1

Cryotherapy destroys warts through thermal-induced cytolysis 2
Surgical removal is reserved for extensive disease or treatment failures, with an efficacy of 93% and a recurrence rate of 29% 1, 3

Podofilox 0.5% solution or gel should be applied twice daily for 3 days, followed by 4 days off therapy, with a total wart area treated not exceeding 10 cm² and a total volume limited to 0.5 mL per day 2, 3
Imiquimod 5% cream should be applied once daily at bedtime, three times weekly for up to 16 weeks, and stimulates interferon and cytokine production 2, 3
Sinecatechins 15% ointment should be applied three times daily until complete clearance, but not longer than 16 weeks, and is a green tea extract with catechins as the active ingredient 2

Treatment should be chosen based on location, wart characteristics, patient factors, and provider experience 1, 3

Pregnant patients should only use cryotherapy or TCA, and avoid podophyllin, podofilox, imiquimod, and sinecatechins 1, 2, 3
HIV-positive/immunocompromised patients may have reduced treatment response and higher recurrence rates, and should avoid sinecatechins 1, 2

20-30% of genital warts clear spontaneously within 3 months without treatment, and recurrence is common (approximately 30%) regardless of treatment method 1
Treatment removes visible warts but does not eliminate the underlying HPV virus 1, 2
HPV types 6 and 11 cause over 90% of genital warts and are low-risk types that do not cause cancer 1

Intra-anal warts should not be treated in primary care, and require specialist management 1
The recommended treatment areas or volumes for podofilox should not be exceeded (10 cm², 0.5 mL/day) 2, 3
Podophyllin, podofilox, imiquimod, or sinecatechins should not be used in pregnancy 1, 2, 3